Our top pick for
UFP Technologies Inc is a packaging & containers business based in the US. UFP Technologies shares (UFPT) are listed on the NASDAQ and all prices are listed in US Dollars. UFP Technologies employs 860 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$62.70|
|52-week range||$36.69 - $71.17|
|50-day moving average||$64.35|
|200-day moving average||$59.10|
|Wall St. target price||$78.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$2.12|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-1.75%|
|1 month (2021-09-24)||0.79%|
|3 months (2021-07-23)||4.71%|
|6 months (2021-04-23)||24.50%|
|1 year (2020-10-23)||58.65%|
|2 years (2019-10-24)||56.79%|
|3 years (2018-10-24)||102.19%|
|5 years (2016-10-24)||133.96%|
Valuing UFP Technologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of UFP Technologies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
UFP Technologies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 30x. In other words, UFP Technologies shares trade at around 30x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
UFP Technologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $28.6 million.
The EBITDA is a measure of a UFP Technologies's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$187.7 million|
|Operating margin TTM||10.83%|
|Gross profit TTM||$44.7 million|
|Return on assets TTM||6.13%|
|Return on equity TTM||9.02%|
|Market capitalisation||$480.7 million|
TTM: trailing 12 months
There are currently 47,132 UFP Technologies shares held short by investors – that's known as UFP Technologies's "short interest". This figure is 11.7% down from 53,348 last month.
There are a few different ways that this level of interest in shorting UFP Technologies shares can be evaluated.
UFP Technologies's "short interest ratio" (SIR) is the quantity of UFP Technologies shares currently shorted divided by the average quantity of UFP Technologies shares traded daily (recently around 26628.248587571). UFP Technologies's SIR currently stands at 1.77. In other words for every 100,000 UFP Technologies shares traded daily on the market, roughly 1770 shares are currently held short.
However UFP Technologies's short interest can also be evaluated against the total number of UFP Technologies shares, or, against the total number of tradable UFP Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case UFP Technologies's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 UFP Technologies shares in existence, roughly 10 shares are currently held short) or 0.0078% of the tradable shares (for every 100,000 tradable UFP Technologies shares, roughly 8 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against UFP Technologies.
Find out more about how you can short UFP Technologies stock.
We're not expecting UFP Technologies to pay a dividend over the next 12 months.
Over the last 12 months, UFP Technologies's shares have ranged in value from as little as $36.69 up to $71.17. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while UFP Technologies's is 1.0148. This would suggest that UFP Technologies's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
UFP Technologies, Inc. designs and custom manufactures components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics primarily for the medical market. Its single-use and single-patient devices and components are used in a range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The company also provides engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets. The applications of these products include military uniform and gear components, automotive interior trim, athletic padding, environmentally protective packaging, air filtration, abrasive nail files, and protective cases and inserts. It markets and sells its products in the United States principally through a direct sales force, as well as independent manufacturer representatives. UFP Technologies, Inc.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.